Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Endometrial Hyperplasia × Cyproterone acetate, ethinyl estradiol drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Progesterone Resistance 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1

Interventions

Letrozole 2 ricin A-GnRH conjugate 1 Progesterone 1 Medroxyprogesterone Acetate 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Gonadotropin-Releasing Hormone 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05316935 2025-08-11

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Fudan University

Phase 2/3 Recruiting

Progesterone Resistance, Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡